Targeted Therapies in Sarcomas: Challenging the Challenge

Figure 3

AKT activation, among other stimulus, can activate mTOR complexes, mTORC1 and mTORC2, promoting protein synthesis and cell proliferation. Rapamycin and rapalogs are specific inhibitors of mTORC1 but an escape route remains through mTORC2 activity.